WSW, NY, 18th December 2025, FinanceWire … Read More
VOO
Nuvectis Pharma’s New Phase 1b Trial Targets a Major Lung Cancer Bottleneck (NASDAQ: NVCT)
WSW, NY, 17th December 2025, FinanceWire … Read More
Silexion Therapeutics Receives $6 Price Target and Buy Rating From Litchfield Hills Research (NASDAQ: SLXN)
WSW, NY, 15th December 2025, FinanceWire … Read More
InterCure May Be Uniquely Positioned as Trump’s Cannabis Rescheduling Returns to Headlines (NASDAQ: INCR)
WSW, NY, 12th December 2025, FinanceWire … Read More
Inspira Technologies May be Perfectly Positioned as Flu Cases Increase and Respiratory Complexity Grows (NASDAQ: IINN)
WSW, NY, 11th December 2025, FinanceWire … Read More
Alpha Tau Medical Just Treated Its First Brain Tumor Patient – and It Could Mark an Inflection Point for the Company (NASDAQ: DRTS)
WSW, NY, 10th December 2025, FinanceWire … Read More
PolyPid Clears a Key FDA Milestone, Reducing Regulatory Risk Ahead of Its Planned NDA Filing (NASDAQ: PYPD)
WSW, NY, 5th December 2025, FinanceWire … Read More
DarioHealth is Gaining Strong Momentum as GLP-1 Costs Reshape Employer Health Strategy (NASDAQ: DRIO)
WSW, NY, 5th December 2025, FinanceWire … Read More
Duke Robotics is Positioning Its Technology to Meet America’s Emerging Grid Security Demands (OTCQB: DUKR)
WSW, NY, 4th December 2025, FinanceWire … Read More
BiomX Is Targeting the Infection Threat Returning to Modern War – And the Military Is Paying Attention (NYSE: PHGE)
WSW, NY, 4th December 2025, FinanceWire … Read More